Adverum Biotechnologies Stock: What Investors Should Know
A breakdown of Adverum Biotechnologies stock performance, pipeline progress, financials, and key risks for investors considering the clinical-stage gene therapy company.
Biotech Investing on Detroit Bureau.
Every article on Detroit Bureau about Biotech Investing — 13 stories covering it, newest first.
A breakdown of Adverum Biotechnologies stock performance, pipeline progress, financials, and key risks for investors considering the clinical-stage gene therapy company.
An overview of Acceleron Pharma's stock price, key drivers, pipeline catalysts, and what investors should watch for ANMT shares going forward.
A practical look at penny stocks in the biotech sector, covering risk, catalysts, and how to separate speculative micro-caps from companies with real development pipelines.
A breakdown of ALNY earnings, what the key metrics mean, and how recent performance shapes the outlook for investors tracking the stock.
A look at the high growth stocks that delivered outsized returns in 2019, the sectors that led, and the lessons investors can carry forward.
An overview of Progenics Pharmaceuticals stock, covering its pipeline, recent developments, financial position, and factors that may influence its market performance.
A clear look at the Nasdaq Biotechnology Index (NBI): which companies it includes, how it is calculated, what drives its moves, and how investors use it to track the biotech sec...
AQST stock data on Yahoo Finance covers price, volume, market cap and key metrics for Aquestive Therapeutics, plus where to find it on the platform.
TRTX stock represents Taretta Therapeutics, a clinical-stage biotech firm focused on rare diseases. This overview covers the company's pipeline, stock performance, trading detai...
A look at the leading biotech stocks, what drives their valuations, and how to evaluate pipeline strength, regulatory risk, and partnerships before investing.
CYCC stock tracks Cyclerion Therapeutics, a clinical-stage biotech focused on nitric oxide-based therapies for pulmonary arterial hypertension and other serious conditions. This...
XBI does not pay a dividend. Learn why the SPDR S&P Biotech ETF distributes no cash, how its total return works, and what biotech investors should consider instead.
A biotech mutual fund pools investor money to hold shares of biotechnology and pharmaceutical companies. This guide covers how these funds work, what drives their performance, k...